Küresel inovasyon ekosistemi etkinliği olan Nexus 2140, teknoloji destekli tüketim için yeni bir manzaranın ortaklaşa inşa edilmesi amacıyla FEC'den yoğun sponsorluk alıyor

Denali Ventures

investment firm

About

Denali Ventures, an investment firm, finances companies with methods for controlling significant disease entities and medical conditions.

  • Herzliya,Tel Aviv,Israel

Details

Founded date
Jan 1, 1998
Operating Status
Active
Investor Type
Venture Capital

Investments

Number of Investments
Number of Lead Investments
6
0
Denali Ventures has made 6 investments. Their most recent investment was on May 20, 2016, when Fanplayr raised $6M.
Date Company Name
Round Money Raised Industry Lead Investor
May 20, 2016 Fanplayr
Series A $6M Ad Targeting
May 15, 2012 Gamida Cell
Series E $10M Biotechnology
Sep 27, 2006 Gamida Cell
Series D $16M Biotechnology
Oct 3, 2002 HyperRoll
Series B $12.50M Architecture
Oct 16, 2001 D Pharm LTD.
Series D $30M Biopharma

Employee Profiles

Number of Employee Profiles
3
Denali Ventures has 3 current employee profiles, including Executive Noam Karstaedt
Executive
Executive
Board member

Exits

Denali Ventures has had 3 exits. Denali Ventures most notable exits include Gamida Cell ,   HyperRoll

Date Company Name Exit Type Industry
Oct 25, 2018 Gamida Cell IPO Biotechnology Detail
Sep 29, 2009 HyperRoll M&A Architecture Detail
Aug 17, 2009 D Pharm LTD. IPO Biopharma Detail